Search research articles
Contact Us
Filters
Showing results (701-710 of 706) with videos related to
Page
of 71
Sort By:
You have reached the last page of results.
This site can display upto 706 results.
BMC Medicine
|
May 9, 2025
A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Xiaolin Lu, Tao Dai, Xue Chen, et al.
Haematologica
|
February 1, 2024
The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry group
Zheng-Li Xu, Lan-Ping Xu, Yi-Cheng Zhang, et al.
Journal of Extracellular Vesicles
|
June 2, 2026
Tumour-Derived Extracellular Vesicles Reprogramme Tumour-Associated Macrophages Into Immunosuppressive Phenotype via NOD1 Signalling in Clear Cell Renal Cell Carcinoma
Xiu-Wu Pan, Mu-Chen Li, Tian-Yue Yang, et al.
Nature Biomedical Engineering
|
October 1, 2025
Large-scale visualization of α-synuclein oligomers in Parkinson's disease brain tissue
Rebecca Andrews, Bin Fu, Christina E Toomey, et al.
The Lancet. Oncology
|
September 4, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
Aiping Zhou, Pengfei Shen, Juan Li, et al.
Global Change Biology
|
April 14, 2020
Plastic pollution in croplands threatens long-term food security
Dan Zhang, Ee Ling Ng, Wanli Hu, et al.
Page
of 71
Search research articles
Search
Showing results (701-710 of 706) with videos related to
Sort By:
Page
of 71
You have reached the last page of results.
This site can display upto 706 results.
BMC Medicine
|
May 9, 2025
A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Xiaolin Lu, Tao Dai, Xue Chen, et al.
Haematologica
|
February 1, 2024
The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry group
Zheng-Li Xu, Lan-Ping Xu, Yi-Cheng Zhang, et al.
Journal of Extracellular Vesicles
|
June 2, 2026
Tumour-Derived Extracellular Vesicles Reprogramme Tumour-Associated Macrophages Into Immunosuppressive Phenotype via NOD1 Signalling in Clear Cell Renal Cell Carcinoma
Xiu-Wu Pan, Mu-Chen Li, Tian-Yue Yang, et al.
Nature Biomedical Engineering
|
October 1, 2025
Large-scale visualization of α-synuclein oligomers in Parkinson's disease brain tissue
Rebecca Andrews, Bin Fu, Christina E Toomey, et al.
The Lancet. Oncology
|
September 4, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
Aiping Zhou, Pengfei Shen, Juan Li, et al.
Global Change Biology
|
April 14, 2020
Plastic pollution in croplands threatens long-term food security
Dan Zhang, Ee Ling Ng, Wanli Hu, et al.
Page
of 71